Tenaya raises $52.5m to push forward gene therapy trials
Longevity Technology - 05-Mar-2025The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Join the club for FREE to access the whole archive and other member benefits.
Restoring the body with gene therapy.
The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Scientists aim to create cold-adapted elephants to restore Arctic ecosystems
Verve regains full rights to its liver disease program as it moves forward independently
Regeneron’s DB-OTO offers new hope for genetic hearing loss
Click on resource name for more details.
Company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies
Biotechnology company focused on developing liver directed gene therapies for a range of diseases
Book written by virologist Nessa Carey
manipulation over the Opportunities opened up with human genetic engineering need to be regulated global to avoid exploitation
Genome editing combined with stem cell generation could produce life extending therapies when boosted with big data
Including nanoparticles for targeted drug delivery, nanofiber sensors, and personalized nerve cells
If you can repair damage from heart attacks, why can't we repair heart damage from ageing?